Abstract
Although cardiac failure has been studied extensively, vascular failure is not a recognizable term. We suggest that it is reasonable to argue that failure of the vessel to control its mass, contractile capacity, and lumen will involve pathways similar to cardiac failure. Vascular failure, or perhaps more accurately arterial failure, has very different consequences. Failure to control mass and external diameter will result in hypertension or loss of lumen in atherosclerosis. We review what is known about this normal remodeling response and its failure, and propose directions for research.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Wolinsky H, Glagov S: A lamellar unit of aortic medial structure and function in mammals. Circ Res 1967, 20:99–101.
Glagov S, Weisenberg E, Zarins CK, et al.: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987, 316:1371–1375.
Folkow B: Physiological aspects of primary hypertension. Physiol Rev 1982, 62:347–504.
Cho A, Mitchell L, Koopmans D, Langille BL: Effects of changes in blood flow rate on cell death and cell proliferation in carotid arteries of immature rabbits. Circ Res 1997, 81:328–337.
Mulvany MJ, Hansen PK, Aalkjaer C: Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 1978, 43:854–863.
Mulvany MJ: Resistance vessel growth and remodeling: cause or consequence in cardiovascular disease. J Hum Hypertens 1995, 9:479–485.
Bray P, Agrotis A, Bobik A: Transforming growth factor-beta and receptor tyrosine kinase-activating growth factors negatively regulate collagen genes in smooth muscle of hypertensive rats. Hypertension 1998, 31:986–994.
Bezie Y, Lamaziere JM, Laurent S, et al.: Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1998, 18:1027–1034.
Himeno H, Crawford DC, Hosoi M, et al.: Angiotensin II alters aortic fibronectin independently of hypertension. Hypertension 1994, 23:823–826.
Deindl E, Buschmann I, Hoefer IE, et al.: Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ Res 2001, 89:779–786.
Hoefer IE, van Royen N, Buschmann IR, et al.: Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc Res 2001, 49:609–617.
Swynghedauw B, Baillard C: Biology of hypertensive cardiopathy. Curr Opin Cardiol 2000, 15:247–253.
Nicol RL, Frey N, Olson EN: From the sarcomere to the nucleus: role of genetics and signaling in structural heart disease. Annu Rev Genom Hum Genet 2000, 1:179–223.
Schaub MC, Hefti MA, Harder BA, Eppenberger HM: Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J Mol Med 1997, 75:901–920.
Hunter JJ, Chien KR: Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 1999, 341:1276–1283.
Guyton AC: Kidneys and fluids in pressure regulation. Small volume but large pressure changes. Hypertension 1992, 19:12–18.
Dilley RJ, Schwartz SM: Vascular remodeling in the growth hormone transgenic mouse. Circ Res 1989, 65:1233–1240.
Bohlooly Y, Carlson L, Olsson B, et al.: Vascular function and blood pressure in GH transgenic mice. Endocrinology 2001, 142:3317–3323.
Guyton AC, Coleman TG, Cowley AW Jr, et al.: Systems analysis of arterial pressure regulation and hypertension. Ann Biomed Eng 1972, 1:254–281.
Karet FE, Lifton RP: Mutations contributing to human blood pressure variation. Recent Prog Horm Res 1997, 52:263–276.
O’Brien ER, Alpers CE, Stewart DK, et al.: Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. Circ Res 1993, 73:223–231.
Mintz GS, Kovach JA, Javier SP, et al.: Geometric remodeling is the predominant mechanism of late lumen loss after coronary angioplasty [abstract]. Circulation 1993, 88(4 Pt 2):I-654.
Nissen SE: Clinical images from intravascular ultrasound: coronary disease, plaque rupture, and intervention—the inside view. Am J Cardiol 2001, 88:16K-18K.
Stadius ML, Gown AM, Kernoff R, Schwartz SM: Does sequential balloon injury of an artery lead to a different outcome than a single injury? An experimental study of angioplasty. Coronary Artery Dis 1996, 7:247–255.
Kandabashi T, Shimokawa H, Miyata K, et al.: Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta. Circulation 2000, 101:1319–1323.
Hillebrands JL, Klatter FA, van Dijk WD, Rozing J: Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat Med 2002, 8:194–195.
Shimokawa H: Cellular and molecular mechanisms of coronary artery spasm: lessons from animal models. Jpn Circ J 2000, 64:1–12.
Adams LD, Geary RL, McManus B, Schwartz SM: A comparison of aorta and vena cava medial message expression by cDNA array analysis identifies a set of 68 consistently differentially expressed genes, all in aortic media. Circ Res 2000, 87:623–631.
D’Angelo DD, Sakata Y, Lorenz JN, et al.: Transgenic Gαq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci U S A 1997, 94:8121–8126.
Adams JW, Sakata Y, Davis MG, et al.: Enhanced Gαq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci U S A 1998, 95:10140–10145.
Mende U, Kagen A, Cohen A, et al.: Transient cardiac expression of constitutively active Gαq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci U S A 1998, 95:13893–13898.
Akhter SA, Luttrell LM, Rockman HA, et al.: Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 1998, 280:574–577.
Offermanns S, Zhao LP, Gohla A, et al.: Embryonic cardiomyocyte hypoplasia and craniofacial defects in G alpha q/G alpha 11-mutant mice. Eur Mol Biol Org J 1998, 17:4304–4312.
Sakata Y, Hoit BD, Liggett SB, et al.: Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice. Circulation 1998, 97:1488–1495.
Rogers JH, Tamirisa P, Kovacs A, et al.: RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload. J Clin Invest 1999, 104:567–576.
Rogers JH, Tsirka A, Kovacs A, et al.: RGS4 reduces contractile dysfunction and hypertrophic gene induction in Gαq overexpressing mice. J Mol Cell Cardiol 2001, 33:209–218.
Vuong TM, Chabre M: Deactivation kinetics of the transduction cascade of vision. Proc Natl Acad Sci U S A 1991, 88:9813–9817.
Kazlauskas A, Bowen-Pope DF, Seifert RA, et al.: Different effects of homo- and heterodimers of platelet-derived growth factor A and B chains on human and mouse fibroblasts. Eur Mol Biol Org J 1988, 7:3727–3735.
Somlyo AP, Somlyo AV: Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol (London) 2000, 522(Pt 2):177–185.
Kamm KE, Stull JT: Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem 2001, 276:4527–4530.
Pfitzer G: Invited review: regulation of myosin phosphorylation in smooth muscle. J Appl Physiol 2001, 91:497–503.
Yamakawa T, Tanaka S, Numaguchi K, et al.: Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells. Hypertension 2000, 35:313–318.
Numaguchi K, Eguchi S, Yamakawa T, et al.: Mechanotransduction of rat aortic vascular smooth muscle cells requires RhoA and intact actin filaments. Circ Res 1999, 85:5–11.
Miao H, Li S, Hu YL, et al.: Differential regulation of Rho GTPases by beta1 and beta3 integrins: the role of an extracellular domain of integrin in intracellular signaling. J Cell Sci 2002, 115:2199–2206.
Tzima E, del Pozo MA, Shattil SJ, et al.: Activation of integrins in endothelial cells by fluid shear stress mediates Rho-dependent cytoskeletal alignment. Eur Mol Biol Org J 2001, 20:4639–4647.
Lu J, Landerholm TE, Wei JS, et al.: Coronary smooth muscle differentiation from proepicardial cells requires RhoA-mediated actin reorganization and p160 Rho-kinase activity. Dev Biol 2001, 240:404–418.
Seasholtz TM, Zhang T, Morissette MR, et al.: Increased expression and activity of RhoA are associated with increased DNA synthesis and reduced p27(Kip 1) expression in the vasculature of hypertensive rats. Circ Res 2001, 89:488–495.
Lu Q, Sun EE, Klein RS, Flanagan JG: Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell 2001, 105:69–79.
Dulin NO, Sorokin A, Reed E, et al.: RGS3 inhibits G protein-mediated signaling via translocation to the membrane and binding to Gα11. Mol Cell Biol 1999, 19:714–723.
Saitoh O, Masuho I, Terakawa I, et al.: Regulator of G protein signaling 8 (RGS8) requires its NH2 terminus for subcellular localization and acute desensitization of G protein-gated K+ channels. J Biol Chem 2001, 276:5052–5058.
Richardson RM, Marjoram RJ, Barr AJ, Snyderman R: RGS4 inhibits platelet-activating factor receptor phosphorylation and cellular responses. Biochem 2001, 40:3583–3588.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schwartz, S.M., Geary, R.L. & Adams, L.D. Vascular failure: A hypothesis. Current Atherosclerosis Reports 5, 201–207 (2003). https://doi.org/10.1007/s11883-003-0025-y
Issue Date:
DOI: https://doi.org/10.1007/s11883-003-0025-y